<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46285" />
  <subtitle />
  <id>http://dspace.bsuedu.ru/handle/123456789/46285</id>
  <updated>2026-04-07T13:52:57Z</updated>
  <dc:date>2026-04-07T13:52:57Z</dc:date>
  <entry>
    <title>Development of novel effective agents from 1H-indolylammonium trifluoroacetates effective against conditionally pathogenic microorganisms</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46695" />
    <author>
      <name>Stepanenko, I. S.</name>
    </author>
    <author>
      <name>Yamashkin, S. A.</name>
    </author>
    <author>
      <name>Platkova, T. N.</name>
    </author>
    <author>
      <name>Kiryutina, A. I.</name>
    </author>
    <author>
      <name>Sorokvasha, I. N.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46695</id>
    <updated>2022-05-13T00:07:56Z</updated>
    <published>2022-01-01T00:00:00Z</published>
    <summary type="text">Title: Development of novel effective agents from 1H-indolylammonium trifluoroacetates effective against conditionally pathogenic microorganisms
Authors: Stepanenko, I. S.; Yamashkin, S. A.; Platkova, T. N.; Kiryutina, A. I.; Sorokvasha, I. N.
Abstract: The problem of antibiotic resistance of microorganisms is becoming more urgent in the twenty-first century. More and more pathogenic microbes are becoming resistant to two or more antibiotics. This problem has become worse into the COVID-19 pandemic</summary>
    <dc:date>2022-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Experimental study of new derivatives of 3-hydroxypyridine as pharmacological agents for the correction of ischemic brain injury after intracerebral hemorrhage</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46693" />
    <author>
      <name>Shcheblykina, O. V.</name>
    </author>
    <author>
      <name>Shcheblykin, D. V.</name>
    </author>
    <author>
      <name>Trunov, K. S.</name>
    </author>
    <author>
      <name>Danilenko, A. P.</name>
    </author>
    <author>
      <name>Lipatov, V. S.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46693</id>
    <updated>2022-05-13T00:07:59Z</updated>
    <published>2022-01-01T00:00:00Z</published>
    <summary type="text">Title: Experimental study of new derivatives of 3-hydroxypyridine as pharmacological agents for the correction of ischemic brain injury after intracerebral hemorrhage
Authors: Shcheblykina, O. V.; Shcheblykin, D. V.; Trunov, K. S.; Danilenko, A. P.; Lipatov, V. S.
Abstract: Limiting the action of secondary injury factors can improve the prognosis in acute cerebral accidents. The aim of the investigation is to study the neuroprotective effects of 3-hydroxypyridine derivatives</summary>
    <dc:date>2022-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Validation of structural-based virtual screening protocols with the PDB Code 3G0B and prediction of the activity of Tinospora crispa compounds as inhibitors of dipeptidyl-peptidase-IV</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46691" />
    <author>
      <name>Andri Prasetiyo</name>
    </author>
    <author>
      <name>Shirly Kumala</name>
    </author>
    <author>
      <name>Esti Mumpuni</name>
    </author>
    <author>
      <name>Raymond R. Tjandrawinata</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46691</id>
    <updated>2022-05-13T00:07:32Z</updated>
    <published>2022-01-01T00:00:00Z</published>
    <summary type="text">Title: Validation of structural-based virtual screening protocols with the PDB Code 3G0B and prediction of the activity of Tinospora crispa compounds as inhibitors of dipeptidyl-peptidase-IV
Authors: Andri Prasetiyo; Shirly Kumala; Esti Mumpuni; Raymond R. Tjandrawinata
Abstract: Brotowali (Tinospora crispa) has been traditionally used as an antidiabetic drug. DPP-IV inhibitor as an antidiabetic will increase insulin secretion. It indirectly escalates incretin hormones, such as Glucagon-Like peptide-1 (GLP-1) which depends on glucose. This study predicts potential compounds from the Brotowali plants, such as DPP-IV inhibitors, using the Molegro Virtual Docker (MVD)</summary>
    <dc:date>2022-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Synthesis, molecular docking, ADMET study and in vitro pharmacological research of 7-(2-chlorophenyl)-4-(4-methylthiazol-5-yl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione as a promising non-opioid analgesic drug</title>
    <link rel="alternate" href="http://dspace.bsuedu.ru/handle/123456789/46672" />
    <author>
      <name>Kravchenko, A. D.</name>
    </author>
    <author>
      <name>Pyatigorskaya, N. V.</name>
    </author>
    <author>
      <name>Brkich, G. E.</name>
    </author>
    <author>
      <name>Yevsieieva, L. V.</name>
    </author>
    <author>
      <name>Kyrychenko, A. V.</name>
    </author>
    <id>http://dspace.bsuedu.ru/handle/123456789/46672</id>
    <updated>2022-05-12T00:09:27Z</updated>
    <published>2022-01-01T00:00:00Z</published>
    <summary type="text">Title: Synthesis, molecular docking, ADMET study and in vitro pharmacological research of 7-(2-chlorophenyl)-4-(4-methylthiazol-5-yl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione as a promising non-opioid analgesic drug
Authors: Kravchenko, A. D.; Pyatigorskaya, N. V.; Brkich, G. E.; Yevsieieva, L. V.; Kyrychenko, A. V.
Abstract: The discovery of novel drugs that can block the transmission of pain signals for treating the pain of various etiologies is an urgent topic in pharmaceutics. The aim of this paper is to synthesize and to investigate in vitro and in silico characteristics of a promising novel compound: 7-(2-chlorophenyl)-4-(4-methylthiazol-5-yl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione (HSV-DKH-0450)</summary>
    <dc:date>2022-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

